James W. Newman Jr. Adial Pharmaceuticals, Inc. (ADIL) insider trading activity

ADIL Quotes by TradingView

James W. Newman Jr. is Director of ADIAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 20,000 shares of ADIL, which is worth approximately $21,000. The most recent transaction as insider was on Dec 30, 2021, when has been sold 10,000 shares (Common Stock) at a price of $2.66 per share, resulting in proceeds of $26,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
0% 3M change
0% 12M change
Total Value Held $21,000

James W. Newman Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 30 2021
BUY
Open market or private purchase
$26,600 $2.66 p/Share
10,000 Added 33.33%
20,000 Common Stock
JWN

James W. Newman Jr.

Director
Charlottesville, VA

Track Institutional and Insider Activities on ADIL

Follow ADIAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADIL shares.

Notify only if

Insider Trading

Get notified when an Adial Pharmaceuticals, Inc. insider buys or sells ADIL shares.

Notify only if

News

Receive news related to ADIAL PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADIL